MétaCan
Menu
← Back to cohort

Abstract 10742: Implication of the Importins KPNA2 and KPNB1 in Pulmonary Arterial Hypertension

2021· article· en· W3215918917 on OpenAlexaff
Sarah‐Eve Lemay, Charifa Awada, Victoria Toro, Charlotte Romanet, Mark Orcholski, Roxane Paulin, Steeve Provencher, Sébastien Bonnet, Olivier Boucherat, François Potus

Bibliographic record

VenueCirculation · 2021
Typearticle
Languageen
FieldMedicine
TopicPulmonary Hypertension Research and Treatments
Canadian institutionsMontreal Heart InstituteUniversité LavalBureau de Coopération InteruniversitaireInstitut universitaire de cardiologie et de pneumologie de Québec
Fundersnot available
KeywordsMedicineApoptosisInhibitor of apoptosisPulmonary hypertensionSurvivinXIAPCancer researchInternal medicineEndocrinologyPathologyBiologyCancerProgrammed cell deathCaspase

Abstract

fetched live from OpenAlex

Pulmonary arterial hypertension (PAH) is a progressive disease characterized by the elevation of mean pulmonary arterial pressure and resistance, culminating in right ventricular failure and premature death. Pulmonary artery smooth muscle cells (PASMCs) isolated from PAH patients exhibit cancer-like phenotypes such as exaggerated proliferation and resistance to apoptosis, key elements contributing to pulmonary arteries (PA) remodeling. Taking benefits of our previously published proteomic study realized on PASMCs isolated from PAH and control patients, we identified the upregulation of importins proteins, namely KPNA2 and KPNB1. The importins contribute to the nucleocytoplasmic shuttling of macromolecules and transcription factors. Cancer studies highlighted the contribution of the KPNA2 and KPNB1 complex in the pro-proliferative and anti-apoptotic phenotypes of cancer cells. Given the cancer-like phenotype of PAH cells, we hypothesized that increased KPNA2-KPNB1 expression promotes PASMCs survival and adverse PA remodeling.We confirmed that KPNA2 and KPNB1 expression is increased in PASMCs and distal PAs isolated from PAH patients compared to controls (western-blot, n=8-9, p<0.05). Similarly, we reported an increased expression of KPNA2-KPNB1 in 3 preclinical models of PH: hypoxic mice, monocrotaline rats and Sugen-hypoxia (Su-Hx) rats (n=8-12, p<0.05). In vitro , molecular (siRNA) and pharmacological (Ivermectin) inhibition of KPNA2-KPNB1 complex decreases PAH-PASMCs proliferation (WB: PCNA; IF: Ki67 and EdU incorporation labeling) and resistance to apoptosis (WB: Survivin; IF: Annexin V labeling) (n=5, p<0.5). Those results are associated with decreased expression of NFAT, NF-kB and STAT3. In vivo , Ivermectin improved PA remodeling (EVG staining) and hemodynamic parameters as assessed by echocardiography (PAAT, TAPSE) and right heart catheterization (RVSP, SV, CO) in Su-Hx rats (n=20, p<0.05). We demonstrated 1) an increased expression of the importins KPNA2 and KPNB1 in PAH, 2) targeting KPNA2-KPNB1 reverses adverse PA remodeling and PH development. Thus, the repurposing of Ivermectin could represent a novel therapeutic strategy from the laboratory bench to patients’ bedside to reverse PAH development.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.006
Threshold uncertainty score0.019

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0060.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.033
GPT teacher head0.286
Teacher spread0.253 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations1
Published2021
Admission routes1
Has abstractyes

Explore more

Same venueCirculation→Same topicPulmonary Hypertension Research and Treatments→French-language works237,207→